GLPwatch
Trials (2081)
Page 22 of 35.
- The Effect of Semaglutide on the Intestinal Flora in Obesity
- ADJUnct Semaglutide Treatment in Type 1 Diabetes
- A Phase 1, Parallel, Single-Dose, Open-Label, Single-Period Study of LY3502970 in Participants With Normal Renal Function and Participants With Renal Impairment.
- Comparison of the Effect of Exenatide Versus Sitagliptin on 24-hour Average Glucose in Patients With Type 2 Diabetes on Metformin or a Thiazolidinedione
- The Separate and Combined Effects of Long-term GIP and GLP-1 Receptor Activation in Patients with Type 2 Diabetes
- Effect of Liraglutide on Subclinical Atherosclerosis in Patients With Type 1 Diabetes Mellitus
- Dose Ranging Study of the GLP-1 Agonist AVE0010 in Metformin-Treated Subjects With Type 2 Diabetes Mellitus
- A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Tirzepatide in People With Type 2 Diabetes Treated With Metformin, SGLT2 Inhibitor or Both
- Exenatide Once Weekly, Cardiovascular Risk and Type-2 Diabetes
- A Trial Investigating the Efficacy and Safety of Insulin Degludec/Liraglutide Injection in Subjects With Type 2 Diabetes
- Effect of AC2993 Compared With Insulin Glargine in Patients With Type 2 Diabetes Also Using Combination Therapy With Sulfonylurea and Metformin
- Weight Trajectories and Predictive Factors After Semaglutide in Patients With Grade 3 and Complicated Obesity
- Tirzepatide in Women With Obesity and Endometrial Intra-epithelial Neoplasia or Grade 1 Endometrial Cancer
- A Study of Tirzepatide (LY3298176) Compared With Dulaglutide on Major Cardiovascular Events in Participants With Type 2 Diabetes
- A Study of Tirzepatide (LY3298176) in Participants With Type 2 Diabetes Mellitus
- A Study in Women With Overweight or Obesity to Test Whether Different Doses of BI 456906 Influence the Amount of a Contraceptive in the Blood
- Safety and Tolerability of Liraglutide in Japanese Subjects With Type 2 Diabetes
- A Trial Investigating the Influence of Oral Semaglutide on the Pharmacokinetics of Levothyroxine and the Influence of Co-administered Tablets on the Pharmacokinetics of Semaglutide Administered Orally in Healthy Subjects.
- Adiponectin in Patients With Metabolic Disorders
- LIRA-ADD2SGLT2i - Liraglutide Versus Placebo as add-on to SGLT2 Inhibitors.
- Daily Liraglutide for Nicotine Dependence
- GLP-1 RA for Stage 1 Type 1 Diabetes
- Weight-loss Drug for Fertility-Sparing Treatment of Atypical Hyperplasia and Low-grade Cancer of the Endometrium
- Post-marketing Surveillance (Special Use-results Surveillance) on Use With Liraglutide (Victoza®)
- Effects of Combined Dapagliflozin and Exenatide Versus Dapagliflozin and Placebo on Ectopic Lipids in Patients With Uncontrolled Type 2 Diabetes Mellitus.
- Young Adults With Early-onset Obesity Treated With Semaglutide
- A Study to Compare Different Doses of RO7795081 With a Placebo or Semaglutide in People With Type 2 Diabetes
- Improving Cardiovascular Disease Diagnosis and Treatment in Kazakhstan Using Metabolic Correction With GLP-1 Drugs
- Feasibility Study of Exenatide by Continuous Subcutaneous Infusion
- GLP1-imaging Before and After Bariatric Surgery
- A Clinical Trial to Examine the Efficacy and Safety of an Investigational Product With and Without Use of Semaglutide on Glycemic Response in Adults With Prediabetes or Type 2 Diabetes
- A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)
- Efficacy and Tolerance of Liraglutide for Weight Loss in Obese Type 2 Diabetic Hemodialysis Patients
- Effect of Liraglutide on Absorption of Paracetamol in Subjects With Type 2 Diabetes
- Clinical Outcomes of Exenatide Versus Basal Insulin
- Research Study Looking at How Well Semaglutide Tablets Taken Once Daily Work in Chinese Adults Who Are Above a Healthy Weight Range (OASIS 3)
- Glucose-dependent INsulinotropic Polypeptide: Effect on Bone Remodelling and Cell Activity (GINEBRA)
- The Effect of Semaglutide on Bone Health
- Efficacy, Safety, and Tolerability of Tirzepatide in Real-World Conditions in Paraguay.
- Investigating the Pharmacokinetics of Subcutaneous Injections With 1 mg/mL, 3 mg/mL, and 10 mg/mL Semaglutide Strengths and the Absolute Bioavailability of Semaglutide
- Effect of Lixisenatide on Postprandial Lipid Profile in Obese Type 2 Diabetic Patients
- A Research Study to See How Well the New Weekly Medicine IcoSema, Which is a Combination of Insulin Icodec and Semaglutide, Controls Blood Sugar Level in People With Type 2 Diabetes Compared to Weekly Insulin Icodec
- Effects of GLP-1 RAs on Weight and Metabolic Indicators in Obese Patients
- Study of Immune Cells in Obese Patients With Type 2 Diabetes Mellitus Treated With Liraglutide
- Exenatide Plus Pioglitazone Versus Insulin in Poorly Controlled T2DM
- A Research Study to Compare a Medicine Called Semaglutide Against Placebo in People With Peripheral Arterial Disease and Type 2 Diabetes
- A Study to Test Whether Survodutide (BI 456906) Helps People Living With Overweight or Obesity Who Also Have Diabetes to Lose Weight
- A Study of Tirzepatide (LY3298176) in Healthy Participants
- A Drug Interaction Study of Cyclosporine and LY3502970 in Healthy Participants
- Tirzepatide Monotherapy in Patients With Wolfram Syndrome Type 1
- A Master Protocol for Semaglutide Effects on Cardiovascular and Obesity-related Outcomes in People With Overweight or Obesity in the Real World
- Semaglutide's Weight Loss Effects in Obesity
- An Evaluation of Exenatide and Rosiglitazone in Subjects With Type 2 Diabetes Mellitus
- A Master Protocol Study of Orforglipron (LY3502970) in Participants With Hypertension and Obesity or Overweight (ATTAIN-Hypertension) GZL2
- Electrophysiological Effects of a Single 10 μg Dose of Exenatide on the 12-Lead Electrocardiogram QT Interval in Healthy Subjects
- A Research Study to Look at How Well CagriSema Helps People Living With Obesity Lose Weight and Maintain Weight Loss in the Long-term
- Impact of Semaglutide on Tobacco Use and Related Health Behaviors
- Effects of GLP-1RA on Body Weight, Metabolism and Fat Distribution in Overweight/Obese Patients With Type 2 Diabetes Mellitus
- A Research Study to Compare Blood Levels of Cagrilintide and Semaglutide After Single Doses of Different Versions of Injectable CagriSema in Adults With Overweight or Obesity
- Testosterone Replacement Therapy and Liraglutide Effects on Weight Loss in Hypogonadism.